December 17th, 2010
Podcast 111: A look back on the year’s most clinically important developments.
Audio Player
Podcast: Play in new window | Download
Subscribe: RSS
Dr. Danielle Scheurer and Joe Elia have a free-form discussion on what’s happened over the past year.
Links to those stories (and, sometimes, interviews) are attached here.
If you’d like to suggest another, or comment on our selection, drop us a note in the comments field.
Discussion-related links (they are all free links):
- Rivaroxaban
- Dabigatran
- Screening for lung cancer with low-dose CT (National Cancer Institute announcement)
- Clinical Conversations interview with a principal investigator on the lung-cancer screening trial
- Annals of Internal Medicine study warning against false-positive findings with CT screening
- Emphasizing chest compressions in CPR (Physician’s First Watch summary)
- Guidelines for clinicians performing CPR (from Circulation)
- Disparate views on PCI’s benefits between patients and their physicians — after informed consent
- U.S. lags behind other developed countries in health measures (Commonwealth Fund report summary)
- National Healthcare Quality Report 2009
Categories: 2010, Annual review, Audio, Uncategorized, Year's top medical stories
Tags: affordable care act, antiplatelet therapy, cardiopulmonary resuscitation, CPR, dabigatran, Informed consent, lung cancer screening, national health, PPI, proton pump inhibitors, Rivaroxaban
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
3 Responses to “Podcast 111: A look back on the year’s most clinically important developments.”
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
Subscribe to Clinical Conversations via Email
Archives
-
Recent Posts
- Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
- Podcast 301: Monkeypox — what to look for, how to treat
- Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
- Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
- Podcast 297: Forget about all that vitamin D testing!!
- Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
- Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
- Podcast 294: PD-1 blockade in locally advanced rectal cancer
- Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin
Always good to review your articles in a condensed form. Well done. Thanks.
Excellent.
Good to listen to a conversation about health policies and technical papers from the doctor’s point of view.
Congratulations!